bromhexine has been researched along with Cancer of Head in 1 studies
Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Spector, ME | 1 |
Gallagher, KK | 1 |
Light, E | 1 |
Ibrahim, M | 1 |
Chanowski, EJ | 1 |
Moyer, JS | 1 |
Prince, ME | 1 |
Wolf, GT | 1 |
Bradford, CR | 1 |
Cordell, K | 1 |
McHugh, JB | 1 |
Carey, T | 1 |
Worden, FP | 1 |
Eisbruch, A | 1 |
Chepeha, DB | 1 |
1 other study available for bromhexine and Cancer of Head
Article | Year |
---|---|
Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status.
Topics: Bromhexine; Carcinoma, Squamous Cell; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Lymph | 2012 |